Barclays’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $555K | Buy |
+30,189
| New | +$347K | ﹤0.01% | 3136 |
|
|
2025
Q3 | – | Sell |
-286
| Closed | -$4.62K | – | 5576 |
|
|
2025
Q2 | $4.62K | Buy |
286
+285
| +28,500% | +$6.03K | ﹤0.01% | 4982 |
|
|
2025
Q1 | $16 | Hold |
1
| – | – | ﹤0.01% | 5170 |
|
|
2024
Q4 | $19 | Hold |
1
| – | – | ﹤0.01% | 5219 |
|
|
2024
Q3 | $13 | Hold |
1
| – | – | ﹤0.01% | 5237 |
|
|
2024
Q2 | $21 | Hold |
1
| – | – | ﹤0.01% | 4778 |
|
|
2024
Q1 | $228 | Hold |
1
| – | – | ﹤0.01% | 4982 |
|
|
2023
Q4 | $179 | Sell |
1
-1
| -50% | -$155 | ﹤0.01% | 5155 |
|
|
2023
Q3 | $228 | Buy |
2
+1
| +100% | +$158 | ﹤0.01% | 4530 |
|
|
2023
Q2 | $132 | Hold |
1
| – | – | ﹤0.01% | 4434 |
|
|
2023
Q1 | $96 | Hold |
1
| – | – | ﹤0.01% | 5000 |
|
|
2022
Q4 | $230 | Buy |
+1
| New | +$147 | ﹤0.01% | 5176 |
|
|
2021
Q4 | – | Sell |
-48
| Closed | -$11K | – | 4363 |
|
|
2021
Q3 | $11K | Sell |
48
-140
| -74% | -$29.6K | ﹤0.01% | 4503 |
|
|
2021
Q2 | $44K | Sell |
188
-122
| -39% | -$31K | ﹤0.01% | 4187 |
|
|
2021
Q1 | $93K | Buy |
310
+190
| +158% | +$68.1K | ﹤0.01% | 4030 |
|
|
2020
Q4 | $45K | Sell |
120
-82
| -41% | -$28.7K | ﹤0.01% | 4450 |
|
|
2020
Q3 | $62K | Sell |
202
-53
| -21% | -$20.3K | ﹤0.01% | 4493 |
|
|
2020
Q2 | $96K | Buy |
255
+84
| +49% | +$23.8K | ﹤0.01% | 4546 |
|
|
2020
Q1 | $39K | Sell |
171
-404
| -70% | -$154K | ﹤0.01% | 5364 |
|
|
2019
Q4 | $304K | Buy |
575
+172
| +43% | +$93.1K | ﹤0.01% | 4715 |
|
|
2019
Q3 | $174K | Buy |
403
+60
| +17% | +$38.6K | ﹤0.01% | 5070 |
|
|
2019
Q2 | $410K | Sell |
343
-204
| -37% | -$244K | ﹤0.01% | 4507 |
|
|
2019
Q1 | $681K | Buy |
547
+423
| +341% | +$484K | ﹤0.01% | 3824 |
|
|
2018
Q4 | $118K | Sell |
124
-143
| -54% | -$172K | ﹤0.01% | 4929 |
|
|
2018
Q3 | $384K | Sell |
267
-5
| -2% | -$7.56K | ﹤0.01% | 4483 |
|
|
2018
Q2 | $438K | Sell |
272
-269
| -50% | -$463K | ﹤0.01% | 4076 |
|
|
2018
Q1 | $878K | Sell |
541
-69
| -11% | -$143K | ﹤0.01% | 3364 |
|
|
2017
Q4 | $1.02M | Buy |
610
+293
| +92% | +$387K | ﹤0.01% | 3088 |
|
|
2017
Q3 | $443K | Buy |
317
+40
| +14% | +$47K | ﹤0.01% | 3738 |
|
|
2017
Q2 | $309K | Buy |
277
+190
| +218% | +$157K | ﹤0.01% | 3977 |
|
|
2017
Q1 | $47K | Buy |
87
+16
| +23% | +$9.82K | ﹤0.01% | 5377 |
|
|
2016
Q4 | $44K | Buy |
71
+1
| +1% | +$624 | ﹤0.01% | 5246 |
|
|
2016
Q3 | $50K | Sell |
70
-88
| -56% | -$67.3K | ﹤0.01% | 4970 |
|
|
2016
Q2 | $115K | Buy |
158
+69
| +78% | +$47.5K | ﹤0.01% | 4309 |
|
|
2016
Q1 | $45K | Hold |
89
| – | – | ﹤0.01% | 4832 |
|
|
2015
Q4 | $45K | Buy |
89
+27
| +44% | +$17.9K | ﹤0.01% | 4859 |
|
|
2015
Q3 | $31K | Buy |
62
+13
| +27% | +$9.39K | ﹤0.01% | 5265 |
|
|
2015
Q2 | $34K | Buy |
+49
| New | +$40.5K | ﹤0.01% | 5381 |
|
|
2014
Q3 | – | Sell |
-83
| Closed | -$66K | – | 7712 |
|
|
2014
Q2 | $66K | Buy |
83
+81
| +4,050% | +$80.6K | ﹤0.01% | 5755 |
|
|
2014
Q1 | $4K | Buy |
+2
| New | +$2.42K | ﹤0.01% | 7270 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM